| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/23/2007 | US20070196379 Methods for treating congestive heart failure |
| 08/23/2007 | US20070196375 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 08/23/2007 | US20070196372 Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) |
| 08/23/2007 | US20070196371 Soluble il-17rcx4 and methods of using in inflammation |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196367 Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
| 08/23/2007 | US20070196364 Pharmaceutical Formulation and Process |
| 08/23/2007 | US20070196356 Topical bite care composition |
| 08/23/2007 | US20070196355 Method to treat atherosclerosis |
| 08/23/2007 | US20070196354 Method of treating diabetes by inhibiting degradation of at least one of crebl1, atf6, and hnf-4 alpha by htra |
| 08/23/2007 | US20070196353 Method for reducing allergenicity in indoor spaces |
| 08/23/2007 | US20070196352 Vegf-induced genes and their therapeutic use |
| 08/23/2007 | US20070196351 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 08/23/2007 | US20070196350 Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment |
| 08/23/2007 | US20070196348 Compositions and methods for the induction and maintenance of quality sleep |
| 08/23/2007 | US20070196347 Methods for preventing neurological events |
| 08/23/2007 | US20070196346 Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer |
| 08/23/2007 | US20070196343 Fibroblast growth factors; endothelial growth factors; assessing efficiency via monitoring levels of creatine phosphokinase-myocardial band (CPK-MB) isoenzymes; acute coronary artery disease; cardiomyopathy; gene therapy |
| 08/23/2007 | US20070196342 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects |
| 08/23/2007 | US20070196337 Recombinant perforin, expression and uses thereof |
| 08/23/2007 | US20070196333 Composition comprising mixtures of IFN-alpha subtypes |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196331 Methods and compositions for mobilizing stem cells |
| 08/23/2007 | US20070196330 Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes |
| 08/23/2007 | US20070196279 Methods for treating progressive neurodegenerative disorders |
| 08/23/2007 | US20070196272 Oral delivery of therapeutic agents using tight junction agonists |
| 08/23/2007 | US20070196269 Pharmaceutical composition |
| 08/23/2007 | US20070193578 Combination Pressure Therapy for Treatment of Ischemia & Heart Conditions, Diabetes, Alzheimer's Disease and Cancer |
| 08/23/2007 | DE102006007146A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 08/23/2007 | DE102006006904A1 Neue Mittel zur Blutstillung und Klebstoffe für medizinische Anwendungen Novel agents for hemostasis and adhesives for medical applications |
| 08/23/2007 | CA2838399A1 Formulations for a tight junction effector |
| 08/23/2007 | CA2822302A1 Methods of impairing osteoclast differentiation |
| 08/23/2007 | CA2642847A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | CA2642539A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 08/23/2007 | CA2642537A1 Vasodilator |
| 08/23/2007 | CA2642389A1 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
| 08/23/2007 | CA2642138A1 Production of foreign nucleic acids and polypeptides in plant systems |
| 08/23/2007 | CA2641342A1 Long-acting polypeptides and methods of producing and administering same |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2638759A1 Protective complement proteins and age-related macular degeneration |
| 08/22/2007 | EP1820862A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820860A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820858A1 Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1820853A2 Recombinant influenza viruses for vaccines and gene therapy |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820516A2 Novel albumin-free factor VIII formulations |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820510A1 Botulinum toxin therapy for skin disorders |
| 08/22/2007 | EP1820509A1 Therapeutic preparation of very high purity FVlla and method for obtaining same |
| 08/22/2007 | EP1820508A1 Coagulation factor X polypeptides with modified activation properties |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1819814A2 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 08/22/2007 | EP1819729A2 Method for producing carboxy-terminal amidified peptides |
| 08/22/2007 | EP1819726A1 Modulation of ovulation |
| 08/22/2007 | EP1819724A1 Compositions containing beta 2-glycoprotein i for the prevention and/or treatment of vascular disease |
| 08/22/2007 | EP1819722A1 Modulation of ovulation |
| 08/22/2007 | EP1819356A1 Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof |
| 08/22/2007 | EP1819355A2 Methods of using chimeric coiled-coil molecule |
| 08/22/2007 | EP1819354A2 Methods and compounds for treating diabetes |
| 08/22/2007 | EP1819353A1 Composition for proteasome inhibition |
| 08/22/2007 | EP1819346A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 08/22/2007 | EP1819336A2 Dose forms comprising vx-950 and their dosage regimen |
| 08/22/2007 | EP1819332A2 Pyrrolopyridine-2-carboxylic acid amides |
| 08/22/2007 | EP1720904A4 Treating or preventing extracellular matrix build-up |
| 08/22/2007 | EP1631586B1 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy |
| 08/22/2007 | EP1622638A4 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 08/22/2007 | EP1599603A4 Methods of diagnosis and prognosis of pancreatic cancer |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1546202B1 Human coagulation factor vii polypeptides |
| 08/22/2007 | EP1513538A4 Novel methods for the delivery of polynucleotides to cells |
| 08/22/2007 | EP1333851B1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 08/22/2007 | EP1303292A4 Chemokine conjugates |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1197032B1 Server-assisted regeneration of a strong secret from a weak secret |
| 08/22/2007 | EP1190040B1 Herpes simplex virus expressing interleukin-12 gene and and its use for treating cancer |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | EP1067138B1 Hydroxyproline derivatives |
| 08/22/2007 | EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases |
| 08/22/2007 | EP0933423B1 Meltrins |
| 08/22/2007 | EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer |
| 08/22/2007 | EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | CN1332979C New type antibiotic peptide of peptaibol and preparing technique |
| 08/22/2007 | CN1332978C Peptide as antagonist of VEGF receptor Flt-1 |
| 08/22/2007 | CN1332977C Novel techykinin peptides, precursor peptides thereof and genes encoding the same |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332715C Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN1332711C Method for administering GLP-1 molecules |
| 08/22/2007 | CN1332648C Microemulsion preconcentrate |
| 08/22/2007 | CN101023185A Biomarkers for monitoring inhibition of impdh pathway |
| 08/22/2007 | CN101022838A Amphipathic proteinaceous coating on nanoporous polymer |
| 08/22/2007 | CN101022833A Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
| 08/22/2007 | CN101022825A Combination therapy for preventing or treating alzheimer's disease, and kit therefor |
| 08/22/2007 | CN101022823A Physiologically active composition based on collagen |